EARLY POSTPARTUM | LATE POSPARTUM | ||||||||
---|---|---|---|---|---|---|---|---|---|
Subjects with infusions | Subjects with infusions | ||||||||
Non-surgical control |
Infusion | mPOA repeated inactivation |
dorsal control |
Non-surgical control |
Infusion | mPOA repeated inactivation |
mPOA single inactivation |
dorsal control |
|
Latency (seconds) | |||||||||
First retrieval | 5.0±3.0 | vehicle | 2.0±0.7 | 3.0±1.0 | 88.5±887.5 | vehicle | 93.5±877.4 | 87.0±893.0 | 113.0±876.0 |
bupivacaine | 648.5±556.5*# | 4.0±2.5 | bupivacaine | 14.0±5.1*# | 2.0±19.0*# | 90.0±915.0 | |||
Reunion litter | 65.0±11.7 | vehicle | 75.0±14.8 | 63.0±3.5 | 1800.0±825.9 | vehicle | 1800.0±217.7 | 1800.0±0.0 | 1800.0±436.7 |
bupivacaine | 1800±0*# | 68.0±6.0 | bupivacaine | 103.0±35.0*# | 105.0±77.0*# | 1800.0±443.0 | |||
Hover over | 273.0±98.7 | vehicle | 174.0±37.0 | 188.0±74.0 | 270.5±121.1 | vehicle | 251.0±107.5 | 242.0±50.0 | 342.0±146.7 |
bupivacaine | 959.5±348.7*# | 238.0±82.5 | bupivacaine | 198.0±33.5 | 201.0±56.5 | 285.0±105.0 | |||
Nursing posture | 910.0±155.2 | vehicle | 830.0±72.0 | 900.0±129.0 | 874.0±294.0 | vehicle | 798.0±215.7 | 849.0±202.5 | 801.0±82.0 |
bupivacaine | 1105.0±455.6 | 870.0±35.0 | bupivacaine | 732.0±142.5 | 827.0±58.0 | 798.0±252.5 | |||
Duration (seconds) | |||||||||
Hover over | 788.0±170.0 | vehicle | 808.5±109.2 | 765.0±115.5 | 495.5±103.1 | vehicle | 518.7±65.4 | 580.0±155.5 | 559.0±117.0 |
bupivacaine | 179.0±138.4*# | 888±119.5 | bupivacaine | 617.0±119.5 | 647.0±127.5 | 582.0±136.2 | |||
Nursing posture | 590.0±102.0 | vehicle | 630.0±147.7 | 612.0±40 | 623.0±168.4 | vehicle | 716.5±85.125 | 599.0±144.0 | 676.0±166.2 |
bupivacaine | 404.5±359.6 | 444±143.5 | bupivacaine | 958.0±192.25 | 752.0±138.5 | 652.0±86.0 | |||
Total time with pups | 1358.0±217.5 | vehicle | 1563.5±87.5 | 1581.0±94.5 | 1180.5±208.1 | vehicle | 1265.0±145.25 | 1421.0±315.0 | 1458.0±96.2 |
bupivacaine | 784.0±348.7*# | 1427.0±189.5 | bupivacaine | 1308.0±209.2*# | 1453.0±1115.0*# | 1375.0±82.5 |
Data are expressed as median ± SIQR.
Significant (P<0.05) difference in responding relative to the vehicle infusion (within group comparison, Wilcoxon matched-pairs signed-ranks test )
significant difference relative to non-surgical control females (between group comparison, Mann—Whitney U test ).